drugset / Trial / NCT02393183
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized clinical trial is designed to evaluate the effect of selected antioxidant vitamins and minerals supplement named as ASTED: 1. β- Carotene (30 mg) 2. Vit C (100 mg) 3. Vit E (Alpha-Tocopherol Acetate): 60-200 IU 4. Calcium phosphate dihydrate (40 mg) 5. Zinc oxide (4 mg, elemental) 6. Copper gluconate (3.5 mg) 7. Sodium selenite 23 mg= Selenium 100 µg 8. Nicotinamide (a form of vit.B3) (10 mg) in patients with mild Thyroid eye disease according to EUGOGO classification. To be given twice a day.
Timeline
- Start
- 2019-07-15
- Primary completion
- 2022-06-15
- Completion
- 2022-12-15
Outcome
Outcome not reported
Stopped: “Do not access to the drug”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASTED | Unknown | — | Oral |